JP2025517635A5 - - Google Patents

Info

Publication number
JP2025517635A5
JP2025517635A5 JP2024564864A JP2024564864A JP2025517635A5 JP 2025517635 A5 JP2025517635 A5 JP 2025517635A5 JP 2024564864 A JP2024564864 A JP 2024564864A JP 2024564864 A JP2024564864 A JP 2024564864A JP 2025517635 A5 JP2025517635 A5 JP 2025517635A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
alkylene
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564864A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025517635A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/020814 external-priority patent/WO2023215367A1/en
Publication of JP2025517635A publication Critical patent/JP2025517635A/ja
Publication of JP2025517635A5 publication Critical patent/JP2025517635A5/ja
Pending legal-status Critical Current

Links

JP2024564864A 2022-05-04 2023-05-03 二環式ピペラジノン及びその治療的使用 Pending JP2025517635A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263338375P 2022-05-04 2022-05-04
US63/338,375 2022-05-04
PCT/US2023/020814 WO2023215367A1 (en) 2022-05-04 2023-05-03 Bicyclic piperazinones and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
JP2025517635A JP2025517635A (ja) 2025-06-10
JP2025517635A5 true JP2025517635A5 (enExample) 2026-05-21

Family

ID=86657016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564864A Pending JP2025517635A (ja) 2022-05-04 2023-05-03 二環式ピペラジノン及びその治療的使用

Country Status (4)

Country Link
US (1) US20250296916A1 (enExample)
EP (1) EP4518968A1 (enExample)
JP (1) JP2025517635A (enExample)
WO (1) WO2023215367A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7825618B2 (ja) 2020-11-06 2026-03-06 サイトキネティックス， インコーポレイテッド 二環式１，４－ジアゼパノン及びその治療的使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100477070B1 (ko) 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6410254B1 (en) 1999-05-18 2002-06-25 Cytokinetics Compositions and assays utilizing ADP or phosphate for detecting protein modulators
US7202051B1 (en) 1999-05-18 2007-04-10 Cytokinetics, Inc. Compositions and assays utilizing ADP or phosphate for detecting protein modulators
US6743599B1 (en) 1999-05-18 2004-06-01 Cytokinetics, Inc. Compositions and assays utilizing ADP or phosphate for detecting protein modulators
US6908921B2 (en) * 2002-12-13 2005-06-21 Merck & Co., Inc. Quinoxalinone derivatives as bradykinin B1 antagonists
WO2006094210A2 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. Tetrahydroquinoxalinone sirtuin modulators
US9566310B2 (en) * 2012-09-10 2017-02-14 Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno Methods of treating muscular dystrophy

Similar Documents

Publication Publication Date Title
JP6798075B2 (ja) 神経筋障害を処置するのにおける使用のための化合物
JP6453214B2 (ja) グリコサミノグリカン誘導体及びその製造方法
JP7614086B2 (ja) カテコール化合物と水溶性ポリマーの切断可能なコンジュゲート及びそれらを使用する治療方法
JP6236077B2 (ja) 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質
JP2019516718A5 (enExample)
RU2014131014A (ru) Димерные соединения-агонисты рецептора fgf (fgfr), способ их получения и их терапевтическое применение
CA2858977A1 (en) Phenyl carbamate compounds for use in alleviating or treating pain
JP2018518537A5 (enExample)
JP2025510741A5 (enExample)
JP2012530703A5 (enExample)
RU2006113700A (ru) Аминозамещенный этиламито-агонисты бэта2-адренергических рецепторов
KR20140084329A (ko) 치료학적 제제의 폴리머 접합체의 피하 전달
JP3839665B2 (ja) 置換２−ベンジルアミノ−２−フェニル−アセトアミド化合物
CA2803825C (en) Phenylcarbamate compound and muscle relaxant containing the same
US7005546B2 (en) Acetamidobenzamide compounds for neurodegenerative disorders
JP7706475B2 (ja) 三環式化合物を含む組み合わせ及びｈｂｖ治療薬物の製造におけるその使用
KR850000872B1 (ko) 3-페녹시-1-알콕시카르보닐알킬아미노-프로판올-2 유도체의 제조 방법
AU2017290238A1 (en) Diprovocims: a new and potent class of tlr agonists
JP2006506348A5 (enExample)
JP6109425B2 (ja) 新規なビフェニル誘導体及びその製造方法
RU2009107132A (ru) Производные простых фенилпрениловых эфиров для лечения когнитивных, нейродегенеративных или нейронных заболеваний или расстройств
JP2004501079A5 (enExample)
JP2024534416A5 (enExample)
CN104211615B (zh) 苯基氟取代的苯乙酸酯化合物及其应用
WO2018191219A1 (en) Novel alpha-hydroxy carboxylic acid and derivatives and other gras- based amide and imide prodrugs of amphetamine compounds and uses thereof